• Leah R Pink, Andrew J Smith, Philip W H Peng, Marilyn J Galonski, Paul S Tumber, David Evans, Doug Gourlay, Lesley Gordon, Geoff Bellingham, Satnam S Nijjar, Larry M Picard, and Allan S Gordon.
• Wasser Pain Management Centre, Mount Sinai Hospital, Toronto, Ontario, Canada. lpink@mtsinai.on.ca
• Pain Res Manag. 2012 Jul 1; 17 (4): 276-80.

BackgroundThe present article outlines the process of instituting an assessment of risk of problematic use of medications with new patients in an ambulatory chronic noncancer pain (CNCP) clinic. It is hoped that the authors' experience through this iterative process will fill the gap in the literature by setting an example of an application of the 'universal precautions' approach to chronic pain management.ObjectivesTo assess the feasibility and utility of the addition of a new risk assessment process and to provide a snapshot of the risk of problematic use of medications in new patients presenting to a tertiary ambulatory clinic treating CNCP.MethodsCharts for the first three months following the institution of an intake assessment for risk of problematic medication use were reviewed. Health care providers at the Wasser Pain Management Centre (Toronto, Ontario) were interviewed to discuss the preliminary findings and provide feedback about barriers to completing the intake assessments, as well as to identify the items that were clinically relevant and useful to their practice.ResultsData were analyzed and examined for completeness. While some measures were considered to be particularly helpful, other items were regarded as repetitive, problematic or time consuming. Feedback was then incorporated into revisions of the risk assessment tool.DiscussionOverall, it is feasible and useful to assess risk for problematic use of medications in new patients presenting to CNCP clinics.ConclusionTo facilitate the practice of assessment, the risk assessment tool at intake must be concise, clinically relevant and feasible given practitioner time constraints.

24 keywords...

hide…